These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 31532052)
1. The prescription of direct oral anticoagulants in the elderly: An observational study of 19 798 Ambulatory subjects. Barben J; Menu D; Rosay C; Vovelle J; Mihai AM; Nuss V; d'Athis P; Putot A; Manckoundia P Int J Clin Pract; 2020 Jan; 74(1):e13420. PubMed ID: 31532052 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Prescribing Practices with Direct Acting Oral Anticoagulant Protocols. Draper E; Parkhurst B; Carley B; Krueger K; Larson T; Griesbach S Am J Cardiovasc Drugs; 2017 Dec; 17(6):475-479. PubMed ID: 28887621 [TBL] [Abstract][Full Text] [Related]
3. The Prescription of Vitamin K Antagonists in a Very Old Population: A Cross-Sectional Study of 8696 Ambulatory Subjects Aged Over 85 Years. Manckoundia P; Rosay C; Menu D; Nuss V; Mihai AM; Vovelle J; Nuémi G; d'Athis P; Putot A; Barben J Int J Environ Res Public Health; 2020 Sep; 17(18):. PubMed ID: 32937847 [TBL] [Abstract][Full Text] [Related]
4. Quality of direct oral anticoagulant prescribing in elderly patients with non-valvular atrial fibrillation: results from a large urban health system. Grant SJ; Kothari S; Gimotty PA; Gooneratne NS; Cuker A J Thromb Thrombolysis; 2018 Jul; 46(1):1-6. PubMed ID: 29611105 [TBL] [Abstract][Full Text] [Related]
5. Direct Oral Anticoagulants versus Vitamin K Antagonists in Patients Aged 80 Years and Older. Manckoundia P; Nuemi G; Hacquin A; Menu D; Rosay C; Vovelle J; Nuss V; Baudin-Senegas C; Barben J; Putot A Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33922331 [TBL] [Abstract][Full Text] [Related]
6. The speed of adoption of new drugs and prescription volume after the amendments in reimbursement coverage: the case of non-vitamin K antagonist oral anticoagulants in South Korea. Son KB BMC Public Health; 2020 May; 20(1):797. PubMed ID: 32460730 [TBL] [Abstract][Full Text] [Related]
7. Burden of Inappropriate Prescription of Direct Oral Anticoagulants at Hospital Admission and Discharge in the Elderly: A Prospective Observational Multicenter Study. Bruneau A; Schwab C; Anfosso M; Fernandez C; Hindlet P Drugs Aging; 2019 Nov; 36(11):1047-1055. PubMed ID: 31486994 [TBL] [Abstract][Full Text] [Related]
8. Switching to Another Oral Anticoagulant and Drug Discontinuation Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Different Direct Oral Anticoagulants. Baker CL; Dhamane AD; Rajpura J; Mardekian J; Dina O; Russ C; Rosenblatt L; Lingohr-Smith M; Lin J Clin Appl Thromb Hemost; 2019; 25():1076029619870249. PubMed ID: 31418293 [TBL] [Abstract][Full Text] [Related]
9. National Trends in Ambulatory Oral Anticoagulant Use. Barnes GD; Lucas E; Alexander GC; Goldberger ZD Am J Med; 2015 Dec; 128(12):1300-5.e2. PubMed ID: 26144101 [TBL] [Abstract][Full Text] [Related]
10. Direct Oral Anticoagulants versus Vitamin K Antagonists in Individuals Aged 80 Years and Older: An Overview in 2021. Azzoug C; Nuémi G; Menu D; De Maistre E; Boulin M; Putot A; Manckoundia P Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674204 [TBL] [Abstract][Full Text] [Related]
11. [Assessing the Impact of in-Hospital Formulary Policies on the Prescription Patterns of Direct Oral Anticoagulants (DOACs)]. Yoshida K; Morikawa G; Kubota K; Okazawa K Yakugaku Zasshi; 2024; 144(10):945-950. PubMed ID: 39358250 [TBL] [Abstract][Full Text] [Related]
12. All-Cause Mortality Risk with Direct Oral Anticoagulants and Warfarin in the Primary Treatment of Venous Thromboembolism. Roetker NS; Lutsey PL; Zakai NA; Alonso A; Adam TJ; MacLehose RF Thromb Haemost; 2018 Sep; 118(9):1637-1645. PubMed ID: 30103250 [TBL] [Abstract][Full Text] [Related]
13. Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices? Alamneh EA; Chalmers L; Bereznicki LR Am J Cardiovasc Drugs; 2016 Jun; 16(3):183-200. PubMed ID: 26862063 [TBL] [Abstract][Full Text] [Related]
14. Stability of direct oral anticoagulants in whole blood and plasma from patients in steady state treatment. McGrail R; Revsholm J; Nissen PH; Grove EL; Hvas AM Thromb Res; 2016 Dec; 148():107-110. PubMed ID: 27835819 [TBL] [Abstract][Full Text] [Related]
15. Apixaban for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in France: The PAROS cross-sectional study of routine clinical practice. Falissard B; Picard F; Mahe I; Hanon O; Touzé E; Danchin N; Lamy FX; Ricci L; Steg PG Arch Cardiovasc Dis; 2019; 112(6-7):400-409. PubMed ID: 31014991 [TBL] [Abstract][Full Text] [Related]
16. [Prospective study of the new oral anticoagulants in private practice: cautious optimism]. Krieger C; Stephan D; Aleil B Ann Cardiol Angeiol (Paris); 2015 Apr; 64(2):68-75. PubMed ID: 25791799 [TBL] [Abstract][Full Text] [Related]
17. Trends in use of warfarin and direct oral anticoagulants in atrial fibrillation in Norway, 2010 to 2015. Kjerpeseth LJ; Ellekjær H; Selmer R; Ariansen I; Furu K; Skovlund E Eur J Clin Pharmacol; 2017 Nov; 73(11):1417-1425. PubMed ID: 28735494 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of anticoagulation selection for acute venous thromboembolism. Badreldin H; Nichols H; Rimsans J; Carter D J Thromb Thrombolysis; 2017 Jan; 43(1):74-78. PubMed ID: 27592341 [TBL] [Abstract][Full Text] [Related]
19. Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments. Eek AK; Øie E; Granas AG Eur J Clin Pharmacol; 2018 Mar; 74(3):323-330. PubMed ID: 29149366 [TBL] [Abstract][Full Text] [Related]